ACCP JOURNALS

Dr. Janelle Perkins, guest editor for the themed issue on Women’s Health in Oncology highlights cancer care challenges specific to women across life stages (menarche, pregnancy, breastfeeding, menopause), including infertility, early menopause, fetal/newborn risks, contraception, and menopausal care, and emphasizes individualized, goal-driven patient–provider discussions. They discuss fertility and reproductive management during treatment, differences among cytotoxic chemotherapy, hormonal agents such as aromatase inhibitors, targeted therapies, and immune checkpoint inhibitors, and communication to clarify expectations and side effects. Perkins summarizes emerging observational data on GLP-1 receptor agonists during breast cancer treatment, including possible cardioprotective benefits amid GI side-effect concerns. Read the full issue at: https://accpjournals.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)1875-9114.womens-health-in-oncology

Are clinical metrics measuring what actually matters? In this episode, JACCP Editor-in-Chief Stuart Haines and new Associate Editor Ty Kiser sit down with Andrea Sikora and Brian Murray (University of Colorado) to discuss their editorial "Keeping the Good in Goodhart's Law: Bridging Key Performance Indicators to Comprehensive Medication Management," written in response to the Clinical Administration PRN Opinion Paper that proposes 15 key performance indicators (KPIs) for clinical pharmacy practice. Drawing on Goodhart's Law and McNamara's Fallacy, Sikora and Murray warn that easy-to-measure tasks like IV-to-PO conversion can crowd out the harder-to-quantify cognitive work of comprehensive medication management (CMM). Using vivid stories from the ICU, they make the case for pairing pharmacist-facing KPIs with structural accountability measures that protect time for the work that matters most.

This episode focuses on missed opportunities to intensify lipid-lowering therapy, highlighting gaps where treatment escalation could improve lipid management and cardiovascular risk reduction. The discussion centers on recognizing when lipid control is inadequate and on the role of the clinical pharmacist in optimizing medications, including PCSK9i, statins, and emerging therapies, to better align with patient risk and treatment goals. Read the full article at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.70209

Drs. Shannon Finks and Sarah McBane discuss their July 2026 narrative review, “Menopausal Hormone Therapy: A Narrative Review of Contemporary Evidence.” They describe menopause as a multisystem transition with vasomotor, mood/cognitive, cardiometabolic, and genitourinary symptoms, noting many women see multiple clinicians before diagnosis. They emphasize that menopausal hormone therapy (MHT) formulation, route, timing, and patient selection matter. They discuss MHT benefits for symptom relief, bone protection, and genitourinary symptoms, nuances around cardiovascular, cancer, and cognition outcomes, FDA labeling updates, and more. The manuscript is available at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.70178

Artificial intelligence (AI) is reshaping how research gets done — and pharmacy practice is no exception. In this episode, Editor-in-Chief Stuart T. Haines sits down with Katie Trinkley, Associate Professor of Medicine at the University of Colorado School of Medicine. Dr. Trinkley recently authored an invited paper in JACCP on Research and Scholarly Methods series regarding the use of AI, and she joins us to unpack what pharmacy researchers need to know right now. From the fundamental differences between predictive and generative AI, to the build-versus-buy decision, to AI's underappreciated role in qualitative research, this conversation offers a practical, rigorous framework for using AI thoughtfully — and why pharmacists are uniquely positioned to lead the way. Read the full manuscript: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.70239

The first in a series of interviews with different leaders in clinical pharmacy: Dr. Peter H. Vlasses. 

Drs. Alan Zillich and Khoa Nguyen speak with Drs. Kathryn Lin and Morgan Stewart (University of Texas at Austin) and Dr. Tony Olson (Geisinger) about clinical pharmacists using ambientAI documentation tools in ambulatory care.

The guests describe workflows using mobile apps integrated with Epic, consent processes, and pharmacist review/editing before signing notes. They discuss implementation rollouts,benefits such as reduced documentation burden, improved attention during encounters, less after-hours work, and support for bilingual Spanish-English visits, as well as challenges like inaccuracies, paraphrasing, and considerations for training student learners. Listen as they summarize their study findings and read the full manuscript here: ⁠https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.70242.

Host Dr. Michael Rybak interviews Drs. Alejandro Perez and Autumn Brenner (UNC Medical Center) about their retrospective study, “Incidence of Acute Kidney Injury with the Use of Nafcillin versus Oxacillin,” comparing 171 nafcillin patients with 467 oxacillin patients. The study found a higher AKI rate with nafcillin (33.3%) versus oxacillin (19.5%), along with higher hypokalemia, suggesting these agents may not be clinically interchangeable from a safety standpoint. They discuss confounding concerns around observed mortality and length-of-stay differences, offer mechanistic explanations, and recommend close monitoring of creatinine and potassium—especially in high-risk patients.

Host Dr. Tom Lodise interviews Dr. Marc Scheetz about his Pharmacotherapy editorial, “AI in ID Pharmacy: We Should Not Be Afraid to Put the CAR (Not the Cart) Before the Horse,” discussing how AI is already mainstream and increasingly used in healthcare. Scheetz uses the Industrial Revolution and the John Henry story to argue clinicians should not compete with machines but learn to make them work with us, as AI can outperform humans in many tasks. His optimistic view is that AI will reduce computer-bound work and preserve human connection in patient care. Read the full editorial at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.70103

In this episode of the JACCP Podcast, host Rob DiDomenico is joined by JACCP Editor in Chief Stuart Haines and Senior Associate Editor Beth Phillips to offer practical guidance for authors seeking to publish in the Journal of the American College of Clinical Pharmacy. With nearly 500 annual submissions and a rejection rate approaching 90% for unsolicited manuscripts, it’s important to put together a strong submission. The conversation covers the journal's scope and mission and addresses the most common reasons manuscripts are rejected, from methodological weaknesses to unsupported conclusions. Stuart and Beth also share actionable tips on following reporting guidelines, strengthening review articles, and exploring the journal's full range of manuscript types. A recurring theme: don't hesitate to pitch your idea before investing weeks in writing.